Cara Care has been added to Bayer’s portfolio as its first DiGA: at the start of 2025, the group is acquiring HiDoc Technologies, the company behind the DiGA. For people with irritable bowel syndrome, the app offers personalised therapy support through nutrition plans, behavioural therapy and symptom diaries.

Bayer published a press release on this:

Erste DiGA von Bayer: Cara Care® für Reizdarm